IL-7 Receptor: A Potential Drug Target (P5681)

Target Name: Interleukin-7 receptor

NCBI ID: P5681

Interleukin-7 receptor

Other Name(s): IL-7 receptor | IL-7R | CD127

IL-7 Receptor: A Potential Drug Target

Interleukin-7 receptor (IL-7 receptor), also known as IL-7R, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin receptor family, which includes several other proteins that play important roles in signaling the actions of interleukins, such as IL-1, IL-2, and IL-9. The IL-7 receptor is involved in the regulation of a wide range of physiological processes, including immune responses, cell growth and differentiation, and tissue repair.

The IL-7 receptor is a protein that is composed of an extracellular domain, a transmembrane region, and an intracellular domain. The extracellular domain of the IL-7 receptor is responsible for its ability to interact with ligand, the molecules that bind to the receptor. The transmembrane region is responsible for the movement of the receptor into the cell and the transduction of signals from the receptor to the intracellular domain. The intracellular domain is responsible for the interaction of the receptor with various signaling molecules and for the regulation of downstream signaling pathways.

The IL-7 receptor is involved in the regulation of a wide range of physiological processes, including immune responses, cell growth and differentiation, and tissue repair. It is involved in the development and regulation of T cells, which are a crucial part of the immune system. The IL-7 receptor is also involved in the regulation of cell growth and differentiation, as well as the regulation of tissue repair.

The IL-7 receptor is a potential drug target and has been the focus of research in recent years. The ability of the IL-7 receptor to regulate immune responses and cell growth makes it an attractive target for therapeutic intervention. Several studies have shown that the IL-7 receptor plays a crucial role in the regulation of immune responses, and that its dysfunction can lead to a variety of immunodeficient conditions, such as autoimmune diseases and cancer.

In addition to its involvement in immune regulation, the IL-7 receptor is also involved in the regulation of cell growth and differentiation. It is known to play a role in the regulation of T cell development and function, and is involved in the regulation of cell proliferation and survival. The IL-7 receptor is also involved in the regulation of angiogenesis, the process by which new blood vessels are formed.

The IL-7 receptor is a transmembrane protein, which means that it spans the entire thickness of the cell membrane. It is held in place by its transmembrane region, which is responsible for the regulation of its intracellular and extracellular interactions. Receptor is able to interact with a wide range of ligands, including other proteins, cytokines, and nucleotides.

The IL-7 receptor is involved in the regulation of a wide range of physiological processes, including immune responses, cell growth and differentiation, and tissue repair. It is a protein that is expressed in various tissues throughout the body and is involved in the regulation of a crucial part of our biology. As research into the IL-7 receptor continues, it is clear that it is an important target for therapeutic intervention.

Protein Name: Interleukin-7 Receptor

The "Interleukin-7 receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Interleukin-7 receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets